Cargando…

Akuter Husten bei erwachsenen Patient*innen

BACKGROUND: Acute cough (< 8 weeks) is a frequent complaint in family practice consultations. The most common cause are respiratory infections. The Guideline „Acute and chronic cough“ of the German College of General Practitioners and Family Physicians (DEGAM) was updated in 2021 and contains rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Krüger, Karen, Heintze, Christoph, Gehrke-Beck, Sabine, Holzinger, Felix
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224654/
https://www.ncbi.nlm.nih.gov/pubmed/37274352
http://dx.doi.org/10.53180/zfa.2022.0169-0177
_version_ 1785050243475177472
author Krüger, Karen
Heintze, Christoph
Gehrke-Beck, Sabine
Holzinger, Felix
author_facet Krüger, Karen
Heintze, Christoph
Gehrke-Beck, Sabine
Holzinger, Felix
author_sort Krüger, Karen
collection PubMed
description BACKGROUND: Acute cough (< 8 weeks) is a frequent complaint in family practice consultations. The most common cause are respiratory infections. The Guideline „Acute and chronic cough“ of the German College of General Practitioners and Family Physicians (DEGAM) was updated in 2021 and contains recommendations for an evidence-based approach for the management of acute cough in primary care. METHODS: The guideline has been updated in accordance with the findings of a systematic search of the literature for international guidelines and systematic reviews. All recommendations were developed by an interdisciplinary guideline committee and agreed by formal consensus. RESULTS: History-taking, exclusion of red flags and a physical examination are the basis of diagnostic evaluation. If an acute, uncomplicated bronchitis is likely, no laboratory tests, sputum diagnostics, or chest x-rays should be performed, and antibiotics should not be administered. Evidence based strategies to avoid antibiotic therapy (delayed prescribing, shared decision making, point-of-care-tests) can be used. There is inadequate evidence for the efficacy of antitussive or expectorant drugs against acute cough. The state of the evidence for phytotherapeutic agents is heterogeneous; clinical importance is minimal. COVID-19 should currently be considered in cases of acute respiratory symptoms. If specific symptoms or red flags occur, further diagnoses in the context of acute cough such as community-acquired pneumonia, influenza disease and exacerbations of chronic respiratory diseases (bronchial asthma, COPD) should be taken into consideration. CONCLUSIONS: These evidence-based recommendations are intended to reduce the use of antibiotics to treat colds and acute bronchitis, for which they are not indicated. Further clinical trials of symptomatic treatments for cough should be performed in order to extend the evidence base.
format Online
Article
Text
id pubmed-10224654
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Medizin
record_format MEDLINE/PubMed
spelling pubmed-102246542023-05-30 Akuter Husten bei erwachsenen Patient*innen Krüger, Karen Heintze, Christoph Gehrke-Beck, Sabine Holzinger, Felix ZFA (Stuttgart) S3-Leitlinie BACKGROUND: Acute cough (< 8 weeks) is a frequent complaint in family practice consultations. The most common cause are respiratory infections. The Guideline „Acute and chronic cough“ of the German College of General Practitioners and Family Physicians (DEGAM) was updated in 2021 and contains recommendations for an evidence-based approach for the management of acute cough in primary care. METHODS: The guideline has been updated in accordance with the findings of a systematic search of the literature for international guidelines and systematic reviews. All recommendations were developed by an interdisciplinary guideline committee and agreed by formal consensus. RESULTS: History-taking, exclusion of red flags and a physical examination are the basis of diagnostic evaluation. If an acute, uncomplicated bronchitis is likely, no laboratory tests, sputum diagnostics, or chest x-rays should be performed, and antibiotics should not be administered. Evidence based strategies to avoid antibiotic therapy (delayed prescribing, shared decision making, point-of-care-tests) can be used. There is inadequate evidence for the efficacy of antitussive or expectorant drugs against acute cough. The state of the evidence for phytotherapeutic agents is heterogeneous; clinical importance is minimal. COVID-19 should currently be considered in cases of acute respiratory symptoms. If specific symptoms or red flags occur, further diagnoses in the context of acute cough such as community-acquired pneumonia, influenza disease and exacerbations of chronic respiratory diseases (bronchial asthma, COPD) should be taken into consideration. CONCLUSIONS: These evidence-based recommendations are intended to reduce the use of antibiotics to treat colds and acute bronchitis, for which they are not indicated. Further clinical trials of symptomatic treatments for cough should be performed in order to extend the evidence base. Springer Medizin 2022-05-01 2022 /pmc/articles/PMC10224654/ /pubmed/37274352 http://dx.doi.org/10.53180/zfa.2022.0169-0177 Text en © Deutscher Ärzteverlag 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle S3-Leitlinie
Krüger, Karen
Heintze, Christoph
Gehrke-Beck, Sabine
Holzinger, Felix
Akuter Husten bei erwachsenen Patient*innen
title Akuter Husten bei erwachsenen Patient*innen
title_full Akuter Husten bei erwachsenen Patient*innen
title_fullStr Akuter Husten bei erwachsenen Patient*innen
title_full_unstemmed Akuter Husten bei erwachsenen Patient*innen
title_short Akuter Husten bei erwachsenen Patient*innen
title_sort akuter husten bei erwachsenen patient*innen
topic S3-Leitlinie
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224654/
https://www.ncbi.nlm.nih.gov/pubmed/37274352
http://dx.doi.org/10.53180/zfa.2022.0169-0177
work_keys_str_mv AT krugerkaren akuterhustenbeierwachsenenpatientinnen
AT heintzechristoph akuterhustenbeierwachsenenpatientinnen
AT gehrkebecksabine akuterhustenbeierwachsenenpatientinnen
AT holzingerfelix akuterhustenbeierwachsenenpatientinnen